Every emerging biopharmaceutical company has an interesting story that describes how they overcame major startup challenges, including study design, funding, and drug targeting strategies. eXIthera is developing a small molecule, EP-7041, to control the blood-clotting pathway and enable healthy blood flow without the concerns of adverse clotting or major bleeding via selective inhibition of Factor […]

For the more than 200,000 patients diagnosed every year with Acute Respiratory Distress Syndrome (ARDS), there are few treatment options. Anywhere from 30 to 50 percent of those diagnosed will die of the disease, according to the American Lung Association. ARDS is a severe form of lung injury, most frequently caused by sepsis, inhalation injuries, […]

Developing a safe and effective treatment for Alzheimer’s has been an increasing focus of pharmaceutical research. But scientists trying to crack the code of this complex disease have sometimes felt trapped in a house of mirrors, following seemingly promising paths and intriguing clues that suddenly and inexplicably recede. The relentless drumbeat of drug failure after […]